{"DataElement":{"publicId":"3437507","version":"1","preferredName":"Clinical Study Lung Carcinoma Histologic Stratification Category","preferredDefinition":"Histology categories of malignant tumor arising from epithelial cells of one of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place (commonly used to define a diagnosis), that will be used to classify patients into starta as part of the randomization process or for purposes of data analysis.","longName":"ClinStudy_Lung_Carc_Hist_Strat","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3437506","version":"1","preferredName":"Clinical Study Lung Carcinoma Histologic Stratification","preferredDefinition":"Classifying patients into strata as part of the randomization process, based on  the histology of malignant tumor arising from epithelial cells of one of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place.","longName":"ClinStudy_Lung_Carc_Hist_Strat","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2430995","version":"1","preferredName":"Study","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical trial.","longName":"C15206","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF10-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3437504","version":"1","preferredName":"Lung Carcinoma Histologic Stratification","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has but two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.:A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004:Of or relating to histology.:The process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"C12468:C2916:C25526:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDD45DAC-9DFC-534A-E040-BB89AD434392","latestVersionIndicator":"Yes","beginDate":"2012-04-16","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-04-16","modifiedBy":"ONEDATA","dateModified":"2012-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDD45DAC-9E0D-534A-E040-BB89AD434392","latestVersionIndicator":"Yes","beginDate":"2012-04-16","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-04-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"CALGB-30801 Registration Worksheet","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015239","version":"4","preferredName":"Lung Tumor Histologic Category","preferredDefinition":"the structural pattern of cancer cells used to define a diagnosis.","longName":"LUNG_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-93FE-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Bronchoalveolar carcinoma (BAC)","valueDescription":"BRONCHOALVEOLAR (BAC)","ValueMeaning":{"publicId":"2558343","version":"1","preferredName":"BRONCHOALVEOLAR (BAC)","longName":"2558343","preferredDefinition":"BRONCHOALVEOLAR (BAC)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9400-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Carcinoid","valueDescription":"Carcinoid","ValueMeaning":{"publicId":"2567209","version":"1","preferredName":"Carcinoid","longName":"2567209","preferredDefinition":"Carcinoid","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D396-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"ONEDATA","dateModified":"2003-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9402-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Combined/mixed","valueDescription":"COMBINED/MIXED, SPECIFY SUBCATEGORIES","ValueMeaning":{"publicId":"2558534","version":"1","preferredName":"COMBINED/MIXED, SPECIFY SUBCATEGORIES","longName":"2558534","preferredDefinition":"COMBINED/MIXED, SPECIFY SUBCATEGORIES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B1B3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9404-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Large cell carcinoma","valueDescription":"Large cell carcinoma","ValueMeaning":{"publicId":"2567205","version":"1","preferredName":"Large cell carcinoma","longName":"2567205","preferredDefinition":"Large cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Carcinoma","conceptCode":"C3780","definition":"A malignant epithelial neoplasm composed of large, atypical cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D392-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9406-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Large cell undifferentiated","valueDescription":"Large cell undifferentiated","ValueMeaning":{"publicId":"2570398","version":"1","preferredName":"Large cell undifferentiated","longName":"2570398v1.00","preferredDefinition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Large Cell Carcinoma","conceptCode":"C4450","definition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E00B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9408-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"No malignancy observed","valueDescription":"NO MALIGNANCY OBSERVED","ValueMeaning":{"publicId":"2559533","version":"1","preferredName":"NO MALIGNANCY OBSERVED","longName":"2559533","preferredDefinition":"NO MALIGNANCY OBSERVED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B59A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-940A-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Non-small cell lung cancer NOS","valueDescription":"NON-SMALL CELL LUNG CANCER (NSCLC), NOS","ValueMeaning":{"publicId":"2559572","version":"1","preferredName":"NON-SMALL CELL LUNG CANCER (NSCLC), NOS","longName":"2559572","preferredDefinition":"NON-SMALL CELL LUNG CANCER (NSCLC), NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-940C-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other specify","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-940E-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pre-malignant changes observed","valueDescription":"PRE-MALIGNANT CHANGES OBSERVED","ValueMeaning":{"publicId":"2559849","version":"1","preferredName":"PRE-MALIGNANT CHANGES OBSERVED","longName":"2559849","preferredDefinition":"PRE-MALIGNANT CHANGES OBSERVED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6D6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9410-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Small cell carcinoma (oat cell)","valueDescription":"Small cell carcinoma (oat cell)","ValueMeaning":{"publicId":"2567206","version":"1","preferredName":"Small cell carcinoma (oat cell)","longName":"2567206","preferredDefinition":"Small cell carcinoma (oat cell)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D393-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"ONEDATA","dateModified":"2003-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9412-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous cell carcinoma","ValueMeaning":{"publicId":"2574081","version":"1","preferredName":"Squamous cell carcinoma","longName":"2574081","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD154DA9-9414-74B4-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"SBREXT","dateModified":"2007-06-22","deletedIndicator":"No"},{"value":"Adenocarcinoma with BAC features","valueDescription":"Adenocarcinoma with BAC features","ValueMeaning":{"publicId":"2576115","version":"1","preferredName":"Adenocarcinoma with BAC features","longName":"2576115","preferredDefinition":"Adenocarcinoma with BAC features","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F660-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-01","modifiedBy":"CAMPBELB","dateModified":"2005-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FFB80DD4-0136-42D1-E034-0003BA3F9857","beginDate":"2005-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-01","modifiedBy":"ONEDATA","dateModified":"2005-09-01","deletedIndicator":"No"},{"value":"Large cell with neuroendocrine features","valueDescription":"Large cell with neuroendocrine features","ValueMeaning":{"publicId":"2576116","version":"1","preferredName":"Large cell with neuroendocrine features","longName":"2576116v1.00","preferredDefinition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Large Cell Neuroendocrine Carcinoma","conceptCode":"C6875","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant large cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F661-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-01","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FFB80DD4-013A-42D1-E034-0003BA3F9857","beginDate":"2005-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-01","modifiedBy":"ONEDATA","dateModified":"2005-09-01","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22C93C99-F013-0B52-E044-0003BA3F9857","beginDate":"2006-11-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-11-21","modifiedBy":"ONEDATA","dateModified":"2006-11-21","deletedIndicator":"No"},{"value":"Benign mass","valueDescription":"Benign mass","ValueMeaning":{"publicId":"2582113","version":"1","preferredName":"Benign mass","longName":"2582113","preferredDefinition":"Benign mass","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0DCE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-11-21","modifiedBy":"ALAIS","dateModified":"2006-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"22C904FC-6208-0B4C-E044-0003BA3F9857","beginDate":"2006-11-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-11-21","modifiedBy":"ONEDATA","dateModified":"2006-11-21","deletedIndicator":"No"},{"value":"Other Non-Small Cell Lung Cancer","valueDescription":"Non-Small Cell Lung Carcinoma","ValueMeaning":{"publicId":"2581628","version":"1","preferredName":"Non-Small Cell Lung Carcinoma","longName":"2581628","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"29880511-B32E-5786-E044-0003BA3F9857","beginDate":"2007-02-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-15","modifiedBy":"ONEDATA","dateModified":"2007-02-15","deletedIndicator":"No"},{"value":"Small cell lung cancer","valueDescription":"Small Cell Lung Cancer","ValueMeaning":{"publicId":"2734393","version":"1","preferredName":"Small Cell Lung Cancer","longName":"2734393","preferredDefinition":"Small Cell Lung Cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"482BC433-0B1E-07B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-03-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"482BC4B8-4F7C-07B6-E044-0003BA3F9857","beginDate":"2008-03-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-03-11","modifiedBy":"ONEDATA","dateModified":"2008-03-11","deletedIndicator":"No"},{"value":"Adenosquamous","valueDescription":"ADENOSQUAMOUS CARCINOMA","ValueMeaning":{"publicId":"2558186","version":"1","preferredName":"ADENOSQUAMOUS CARCINOMA","longName":"2558186v1.00","preferredDefinition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B057-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"58EA14E4-4F60-1718-E044-0003BA3F9857","beginDate":"2008-10-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-10-10","modifiedBy":"ONEDATA","dateModified":"2008-10-10","deletedIndicator":"No"},{"value":"Mixed <= 50% squamous cell carcinoma","valueDescription":"Mixed <= 50% squamous cell carcinoma","ValueMeaning":{"publicId":"2866513","version":"1","preferredName":"Mixed <= 50% squamous cell carcinoma","longName":"2866513","preferredDefinition":"Mixed <= 50% squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68C804E8-525D-037F-E040-BB89AD437951","latestVersionIndicator":"Yes","beginDate":"2009-04-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68C804E8-5276-037F-E040-BB89AD437951","beginDate":"2009-04-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-04-30","modifiedBy":"ONEDATA","dateModified":"2009-04-30","deletedIndicator":"No"},{"value":"Mixed > 50% squamous cell carcinoma","valueDescription":"Mixed > 50% squamous cell carcinoma","ValueMeaning":{"publicId":"2866514","version":"1","preferredName":"Mixed > 50% squamous cell carcinoma","longName":"2866514","preferredDefinition":"Mixed > 50% squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68C804E8-5280-037F-E040-BB89AD437951","latestVersionIndicator":"Yes","beginDate":"2009-04-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"68C804E8-5299-037F-E040-BB89AD437951","beginDate":"2009-04-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-04-30","modifiedBy":"ONEDATA","dateModified":"2009-04-30","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E4C44DC-2032-32E2-E040-BB89AD4321BB","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-09","modifiedBy":"ONEDATA","dateModified":"2009-07-09","deletedIndicator":"No"},{"value":"Mixed >= 50% squamous cell carcinoma","valueDescription":"Mixed >= 50% squamous cell carcinoma","ValueMeaning":{"publicId":"3049837","version":"1","preferredName":"Mixed >= 50% squamous cell carcinoma","longName":"3049837","preferredDefinition":"Mixed >= 50% squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83832D8D-AE12-685A-E040-BB89AD435C54","latestVersionIndicator":"Yes","beginDate":"2010-04-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83832D8D-AE2B-685A-E040-BB89AD435C54","beginDate":"2009-04-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-04-05","modifiedBy":"ONEDATA","dateModified":"2010-04-05","deletedIndicator":"No"},{"value":"Mixed < 50% squamous cell carcinoma","valueDescription":"Mixed < 50% squamous cell carcinoma","ValueMeaning":{"publicId":"3049836","version":"1","preferredName":"Mixed < 50% squamous cell carcinoma","longName":"3049836","preferredDefinition":"Mixed < 50% squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83832D8D-ADEF-685A-E040-BB89AD435C54","latestVersionIndicator":"Yes","beginDate":"2010-04-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83832D8D-AE08-685A-E040-BB89AD435C54","beginDate":"2009-04-30","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-04-05","modifiedBy":"ONEDATA","dateModified":"2010-04-05","deletedIndicator":"No"},{"value":"Sarcomatoid","valueDescription":"Sarcomatoid","ValueMeaning":{"publicId":"3027139","version":"1","preferredName":"Sarcomatoid","longName":"3027139","preferredDefinition":"Sarcomatoid carcinoma of the lung is defined by the World Health Organization as poorly differentiated non-small cell carcinoma that contains a component of sarcoma or sarcoma-like elements and represent an overall continuum of epithelial and mesenchymal differentiation.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DC6AB6-C666-CB06-E040-BB89AD437762","latestVersionIndicator":"Yes","beginDate":"2010-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81DC6AB6-C67F-CB06-E040-BB89AD437762","beginDate":"2010-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-03-15","modifiedBy":"ONEDATA","dateModified":"2010-03-15","deletedIndicator":"No"},{"value":"Non-Squamous cell carcinoma","valueDescription":"Non-squamous cell carcinoma","ValueMeaning":{"publicId":"2932105","version":"1","preferredName":"Non-squamous cell carcinoma","longName":"2932105","preferredDefinition":"A poorly differentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular or squamous differentiation.  There is a male predilection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Large Cell Carcinoma","conceptCode":"C4450","definition":"An undifferentiated non-small cell lung carcinoma composed of large polygonal cells without evidence of glandular, squamous, or neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70DF89DB-8A04-2C9A-E040-BB89AD4367D1","latestVersionIndicator":"Yes","beginDate":"2009-08-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-08-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FD6C075-92AE-9FEE-E040-BB89AD43163B","beginDate":"2010-09-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","deletedIndicator":"No"},{"value":"Small Cell Undifferentiated","valueDescription":"Undifferentiated small cell lung cancer","ValueMeaning":{"publicId":"3193550","version":"1","preferredName":"Undifferentiated small cell lung cancer","longName":"3193550","preferredDefinition":"Undifferentiated small cell lung cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D59D36F-43A5-9EDB-E040-BB89AD43280C","latestVersionIndicator":"Yes","beginDate":"2011-02-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-02-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D59D36F-43BE-9EDB-E040-BB89AD43280C","beginDate":"2011-02-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-02-28","modifiedBy":"ONEDATA","dateModified":"2011-02-28","deletedIndicator":"No"},{"value":"Epithelial","valueDescription":"Epithelial Cell","ValueMeaning":{"publicId":"3076544","version":"1","preferredName":"Epithelial Cell","longName":"3076544","preferredDefinition":"Cells that cover the surface of the body and line its cavities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial Cell","conceptCode":"C12578","definition":"Any of the cells of the epithelium, which covers the body and lines its cavities and glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85277787-628E-4197-E040-BB89AD432C40","latestVersionIndicator":"Yes","beginDate":"2010-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B5A279D0-552C-FBB8-E040-BB89AD434279","beginDate":"2012-01-03","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-01-03","modifiedBy":"LEUNGE","dateModified":"2012-08-17","deletedIndicator":"No"},{"value":"Epithelial (epithelioid)","valueDescription":"Epithelial Cell","ValueMeaning":{"publicId":"3076544","version":"1","preferredName":"Epithelial Cell","longName":"3076544","preferredDefinition":"Cells that cover the surface of the body and line its cavities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial Cell","conceptCode":"C12578","definition":"Any of the cells of the epithelium, which covers the body and lines its cavities and glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85277787-628E-4197-E040-BB89AD432C40","latestVersionIndicator":"Yes","beginDate":"2010-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C77AF39C-B1E0-9198-E040-BB89AD433DD2","beginDate":"2012-01-03","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-08-17","modifiedBy":"ONEDATA","dateModified":"2012-08-17","deletedIndicator":"No"},{"value":"Minimally invasive/lepidic adenocarcinoma (BAC)","valueDescription":"Minimally invasive/lepidic adenocarcinoma (BAC)","ValueMeaning":{"publicId":"4367873","version":"1","preferredName":"Minimally invasive/lepidic adenocarcinoma (BAC)","longName":"4367873","preferredDefinition":"Minimally invasive/lepidic adenocarcinoma (BAC)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCADE123-4683-5020-E040-BB89AD432A1E","latestVersionIndicator":"Yes","beginDate":"2014-06-25","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-06-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCADE123-469C-5020-E040-BB89AD432A1E","beginDate":"2014-06-25","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-06-25","modifiedBy":"ONEDATA","dateModified":"2014-06-25","deletedIndicator":"No"},{"value":"Non-lobar and non-diffuse bronchoalveolar cell carcinoma","valueDescription":"Negation Lobar And Negation Diffuse Bronchioloalveolar Carcinoma","ValueMeaning":{"publicId":"4231975","version":"1","preferredName":"Negation Lobar And Negation Diffuse Bronchioloalveolar Carcinoma","longName":"4231975","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Of or relating to or affecting a lobe.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: An operation in which a term denies or inverts the meaning of another term or construction.: widely spread; not localized or confined.: A well or moderately differentiated morphologic variant of lung adenocarcinoma characterized by tumor growth along the alveolar structures without stromal, vascular, or pleural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Lobar","conceptCode":"C25556","definition":"Of or relating to or affecting a lobe.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F4E45A9A-0546-C1F9-E040-BB89AD432EF6","latestVersionIndicator":"Yes","beginDate":"2014-03-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F4E45A9A-058A-C1F9-E040-BB89AD432EF6","beginDate":"2014-03-18","endDate":null,"createdBy":"PATELV","dateCreated":"2014-03-18","modifiedBy":"ONEDATA","dateModified":"2014-03-18","deletedIndicator":"No"},{"value":"Adenocarcinoma in situ","valueDescription":"Adenocarcinoma In Situ","ValueMeaning":{"publicId":"3026016","version":"1","preferredName":"Adenocarcinoma In Situ","longName":"3026016","preferredDefinition":"A lesion in which the normally situated glands are partially or completely replaced by atypical cells with malignant characteristics.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma In Situ","conceptCode":"C4123","definition":"A lesion in which the normally situated glands are partially or completely replaced by atypical cells with malignant characteristics.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81DC6AB6-C16D-CB06-E040-BB89AD437762","latestVersionIndicator":"Yes","beginDate":"2010-03-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F32AFFDD-3854-6C7D-E040-BB89AD431DC1","beginDate":"2014-02-24","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-02-24","modifiedBy":"ONEDATA","dateModified":"2014-02-24","deletedIndicator":"No"},{"value":"Adenocarcinoma (invasive)","valueDescription":"Invasive Adenocarcinoma","ValueMeaning":{"publicId":"4117371","version":"1","preferredName":"Invasive Adenocarcinoma","longName":"4117371","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.: A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0FCE4EA-4A4C-BBE9-E040-BB89AD430980","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F32AFFDD-3869-6C7D-E040-BB89AD431DC1","beginDate":"2014-02-24","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-02-24","modifiedBy":"ONEDATA","dateModified":"2014-02-24","deletedIndicator":"No"},{"value":"Small Cell","valueDescription":"Small cell carcinoma","ValueMeaning":{"publicId":"2567204","version":"1","preferredName":"Small cell carcinoma","longName":"2567204","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D391-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"803A3FCD-D9AD-0AB4-E053-F662850A96E7","beginDate":"2019-01-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","deletedIndicator":"No"},{"value":"Non-Small Cell","valueDescription":"Non-Small Cell Carcinoma","ValueMeaning":{"publicId":"2837836","version":"1","preferredName":"Non-Small Cell Carcinoma","longName":"2837836","preferredDefinition":"A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Small Cell Carcinoma","conceptCode":"C65151","definition":"A malignant epithelial neoplasm characterized by the absence of neoplastic small epithelial cells. A representative example is the lung non-small cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-488E-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"803A3FCD-D9C1-0AB4-E053-F662850A96E7","beginDate":"2019-01-24","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-24","modifiedBy":"ONEDATA","dateModified":"2019-01-24","deletedIndicator":"No"},{"value":"Squamous Metaplasia","valueDescription":"Squamous Metaplasia","ValueMeaning":{"publicId":"2568997","version":"1","preferredName":"Squamous Metaplasia","longName":"2568997","preferredDefinition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Metaplasia","conceptCode":"C3237","definition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA92-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B0F6-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Severe Dysplasia","valueDescription":"Severe Dysplasia","ValueMeaning":{"publicId":"2569004","version":"1","preferredName":"Severe Dysplasia","longName":"2569004","preferredDefinition":"A morphologic finding indicating the presence of severe cellular atypia associated with severe architectural changes in a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Dysplasia","conceptCode":"C8364","definition":"A morphologic finding indicating the presence of severe cellular atypia associated with severe architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA99-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B100-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Low Grade Dysplasia","valueDescription":"Low Grade Dysplasia","ValueMeaning":{"publicId":"6514328","version":"1","preferredName":"Low Grade Dysplasia","longName":"6514328","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Dysplasia","conceptCode":"C156084","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB5B-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B0E2-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Reserve Cell Hyperplasia","valueDescription":"Reserve Cell Hyperplasia","ValueMeaning":{"publicId":"2965043","version":"1","preferredName":"Reserve Cell Hyperplasia","longName":"2965043","preferredDefinition":"The reserve cells proliferate to form two layers of reserve cell hyperplasia beneath the overlying layer of columnar epithelium, and occurs in Gynecologic and lung cancers.  The type of hyperplasia often evolves into squamous hyperplasia.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7A244D8A-52A6-31A8-E040-BB89AD436F56","latestVersionIndicator":"Yes","beginDate":"2009-12-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B10B-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"4494160","version":"1","preferredName":"Normal","longName":"4494160","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"043C792C-06A7-5C4A-E050-BB89AD433FD8","latestVersionIndicator":"Yes","beginDate":"2014-09-29","endDate":null,"createdBy":"RODGERSC","dateCreated":"2014-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B116-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Moderate Dysplasia","valueDescription":"Moderate Dysplasia","ValueMeaning":{"publicId":"2569002","version":"1","preferredName":"Moderate Dysplasia","longName":"2569002","preferredDefinition":"A morphologic finding indicating the presence of moderate cellular atypia associated with moderate architectural changes in a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate Dysplasia","conceptCode":"C8363","definition":"A morphologic finding indicating the presence of moderate cellular atypia associated with moderate architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA97-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B120-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Mild Dysplasia","valueDescription":"Mild Dysplasia","ValueMeaning":{"publicId":"2569000","version":"1","preferredName":"Mild Dysplasia","longName":"2569000","preferredDefinition":"A morphologic finding indicating the presence of mild cellular atypia associated with mild architectural changes in a tissue sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild Dysplasia","conceptCode":"C8362","definition":"A morphologic finding indicating the presence of mild cellular atypia associated with mild architectural changes in a tissue sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA95-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B12B-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Inadequate Specimen","valueDescription":"Inadequate Biospecimen","ValueMeaning":{"publicId":"5080195","version":"1","preferredName":"Inadequate Biospecimen","longName":"5080195","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"266A8AC8-675A-F7AE-E050-BB89AD437109","latestVersionIndicator":"Yes","beginDate":"2015-12-08","endDate":null,"createdBy":"RODGERSC","dateCreated":"2015-12-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B140-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Hyperplastic Leukoplakia","valueDescription":"Hyperplasia Leukoplakia","ValueMeaning":{"publicId":"7670007","version":"1","preferredName":"Hyperplasia Leukoplakia","longName":"7670007","preferredDefinition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.: A white patch or plaque on a mucous membrane that cannot be characterized clinically or pathologically as any other disease. The diagnosis of leukoplakia is one of exclusion; other conditions such as candidiasis, lichen planus, leukoedema, etc., must be ruled out before a diagnosis of leukoplakia can be made. Leukoplakia may be a premalignant condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukoplakia","conceptCode":"C3186","definition":"A white patch or plaque on a mucous membrane that cannot be characterized clinically or pathologically as any other disease. The diagnosis of leukoplakia is one of exclusion; other conditions such as candidiasis, lichen planus, leukoedema, etc., must be ruled out before a diagnosis of leukoplakia can be made. Leukoplakia may be a premalignant condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C31817CA-B14E-2692-E053-4EBD850ABB23","latestVersionIndicator":"Yes","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B167-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Erythroplakia","valueDescription":"Erythroplakia","ValueMeaning":{"publicId":"2573735","version":"1","preferredName":"Erythroplakia","longName":"2573735","preferredDefinition":"Erythroplakia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED14-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-23","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-03-23","modifiedBy":"MAESKEB","dateModified":"2005-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B171-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Carcinoma in Situ","valueDescription":"Carcinoma In Situ","ValueMeaning":{"publicId":"2935534","version":"1","preferredName":"Carcinoma In Situ","longName":"2935534v1.00","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4DE-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":"Updated definition with current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B186-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Carcinoma","valueDescription":"Carcinoma","ValueMeaning":{"publicId":"2935533","version":"1","preferredName":"Carcinoma","longName":"2935533","preferredDefinition":"A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4BB-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B190-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Atypical Cells","valueDescription":"Atypical Cell","ValueMeaning":{"publicId":"7670008","version":"1","preferredName":"Atypical Cell","longName":"7670008","preferredDefinition":"Varying from the norm; not conformable to the type.: The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical","conceptCode":"C25428","definition":"Varying from the norm; not conformable to the type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C31817CA-B19D-2692-E053-4EBD850ABB23","latestVersionIndicator":"Yes","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C31817CA-B1B6-2692-E053-4EBD850ABB23","beginDate":"2021-05-24","endDate":null,"createdBy":"TITARENKOI","dateCreated":"2021-05-24","modifiedBy":"ONEDATA","dateModified":"2021-05-24","deletedIndicator":"No"},{"value":"Not collected/Tissue not sufficient","valueDescription":null,"ValueMeaning":{"publicId":"13983029","version":"1","preferredName":"Tissue Collection Not Done Or Insufficient Sample Volume","longName":"13983029v1.00","preferredDefinition":"A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body._Indicates a task, process or examination that has either not been initiated or not been completed._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An indication that there was not enough sample available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue Collection","conceptCode":"C15339","definition":"A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Insufficient Sample Volume","conceptCode":"C131121","definition":"An indication that there was not enough sample available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF0B3B3D-577D-0D42-E053-731AD00AA129","latestVersionIndicator":"Yes","beginDate":"2023-06-26","endDate":null,"createdBy":"LISU","dateCreated":"2023-06-26","modifiedBy":"LISU","dateModified":"2023-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF0B3B3D-577E-0D42-E053-731AD00AA129","beginDate":"2023-06-26","endDate":null,"createdBy":"LISU","dateCreated":"2023-06-26","modifiedBy":"LISU","dateModified":"2023-06-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208105","version":"1","preferredName":"Histologic Category","preferredDefinition":"Of or relating to histology.:Category; used informally to mean a class of things.","longName":"C25526:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3D9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD154DA9-93E6-74B4-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-06-17","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-17","modifiedBy":"LISU","dateModified":"2023-06-26","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[{"name":"Lung Cancer Histology","type":"Synonym","context":"CTEP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"ClinStudy_Lung_Carc_Hist_Strat","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text1","type":"Alternate Question Text","description":"Pathologic Type","url":null,"context":"CTEP"},{"name":"Lung Tumor Histology","type":"Preferred Question Text","description":"Lung Tumor Histology","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDD45DAC-9E2C-534A-E040-BB89AD434392","latestVersionIndicator":"Yes","beginDate":"2012-04-16","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-04-16","modifiedBy":"FORMBUILDER","dateModified":"2014-07-28","changeDescription":"CALGB-30801 Registration Worksheet","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}